(Q34271690)

1 August 2017

1 reference

title

Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients (English)

1 reference

1 August 2017

Preiksaitis JK

1

1 reference

PubMed ID

11389521

1 August 2017

Keay S

series ordinal

2

1 reference

PubMed ID

11389521

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Clinical Infectious Diseases

1 August 2017

1 reference

1 August 2017

33 Suppl 1

1 reference

1 August 2017

S38-46

1 reference

Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease

1 August 2017

1 reference

Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression

21 January 2018

1 reference

Epstein-Barr virus infections in children after transplantation of the small intestine

21 January 2018

1 reference

Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol

21 January 2018

1 reference

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

21 January 2018

1 reference

Lymphoproliferative disorders after organ transplantation in children

21 January 2018

1 reference

Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients

21 January 2018

1 reference

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

21 January 2018

1 reference

Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders

21 January 2018

1 reference

Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin

21 January 2018

1 reference

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

21 January 2018

1 reference

Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder

21 January 2018

1 reference

Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder

21 January 2018

1 reference

Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus

21 January 2018

1 reference

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

21 January 2018

1 reference

The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation

21 January 2018

1 reference

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

21 January 2018

1 reference

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease

21 January 2018

1 reference

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

21 January 2018

1 reference

Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation

21 January 2018

1 reference

Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases

21 January 2018

1 reference

Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: three-year experience

21 January 2018

1 reference

Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients

21 January 2018

1 reference

Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation

21 January 2018

1 reference

Effects of interferon-alpha therapy on immune parameters in immune thrombocytopenic purpura

21 January 2018

1 reference

Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder

21 January 2018

1 reference

Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

21 January 2018

1 reference

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

21 January 2018

1 reference

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

21 January 2018

1 reference

Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders

21 January 2018

1 reference

Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.

21 January 2018

1 reference

Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation

21 January 2018

1 reference

Cyclosphosphamide/prednisone for combination immunosuppression and therapy of lymphoproliferative disease.

21 January 2018

1 reference

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

21 January 2018

1 reference

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease

21 January 2018

1 reference

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients

21 January 2018

1 reference

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression

21 January 2018

1 reference

POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE OF THE LIVER SUCESSFULLY TREATED BY RETRANSPLANTATION

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/320903

1 reference

1 August 2017

1 reference

PubMed ID

11389521